Skip to main content
Thomas Tu, MD, Cardiology, Louisville, KY, Baptist Health Louisville

ThomasMTuMD

Cardiology Louisville, KY

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Are you Dr. Tu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 98 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Thomas Tu, MD is a cardiologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky, Indiana, and Massachusetts. He is affiliated with Baptist Health Louisville and Baptist Health La Grange.

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Interventional Cardiology, 2002 - 2003
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Cardiovascular Disease, 1999 - 2002
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1996

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2003 - 2025
  • IN State Medical License
    IN State Medical License 2012 - 2019
  • MA State Medical License
    MA State Medical License 1998 - 2005

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients
    Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism PatientsMay 22nd, 2023
  • FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
    FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever SystemMarch 6th, 2023
  • Inari Medical Begins Subject Enrolment in ClotTriever System Trial
    Inari Medical Begins Subject Enrolment in ClotTriever System TrialJanuary 13th, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations